isoproterenol has been researched along with carvedilol in 54 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (11.11) | 18.7374 |
1990's | 9 (16.67) | 18.2507 |
2000's | 16 (29.63) | 29.6817 |
2010's | 18 (33.33) | 24.3611 |
2020's | 5 (9.26) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Gagnon, R; Slivjak, MJ; Smith, EF | 1 |
Carugo, S; Cattaneo, BM; Giannattasio, C; Grassi, G; Mancia, G; Mangoni, AA; Seravalle, G; Zanchetti, A | 1 |
Gellai, M; Nichols, AJ; Ruffolo, RR | 1 |
Bartsch, W; Böhm, E; Borbe, HO; Kling, L; Martin, U; Müller-Beckmann, B; Sponer, G; Strein, K | 1 |
Bartsch, W; Böhm, E; Müller-Beckmann, B; Sponer, G; Strein, K | 1 |
Colindres, RE; Cubeddu, LX; Fuenmayor, N; Powell, JR; Varin, F; Villagra, VG | 2 |
Ashton, DJ; Hieble, JP; Nichols, AJ; Ruffolo, RR; Sulpizio, AC | 1 |
Komori, K; Nagao, T; Seki, N; Suzuki, H | 1 |
Bompart, F; Graham, BR; Liu, JB; Prichard, BN; Tomlinson, B | 1 |
Irlbeck, M; Zimmer, HG | 1 |
Guy, S; McDermott, BJ; Riddell, JG; Shanks, RG; Tham, TC | 1 |
Böhm, M; Ettelbrück, S; Flesch, M; Knorr, A; Maack, C; Paul, M; Pinto, YM; Teisman, AC; van Gilst, WH; Zolk, O | 1 |
Abuin, L; Cotecchia, S; Lattion, A; Nenniger-Tosato, M | 1 |
Grace, AA; Kaumann, AJ; Lowe, MD | 1 |
Ikeda, U; Kurosaki, K; Maeda, Y; Shimada, K | 1 |
Higaki, J; Kotani, N; Moriguchi, A; Nakagami, H; Ogihara, T | 1 |
Chen, J; Christopher, TA; Gao, F; Gu, J; Lopez, BL; Lysko, P; Ma, XL; Ohlstein, EH; Ruffolo, RR; Yue, TL | 1 |
Böhm, M; Cremers, B; Ettelbrück, S; Flesch, M; Maack, C; Rosenkranz, S; Schlüter, KD; Zolk, O | 1 |
Iida, K; Kawano, S; Masumi, T; Nishi, I; Yamaguchi, I | 1 |
Bölck, B; Brixius, K; Bundkirchen, A; Mehlhorn, U; Schwinger, RH | 1 |
Ishikawa, Y; Sasaki, T; Uechi, M; Ueno, K; Yamamoto, T | 1 |
Vita, JA | 1 |
Böhm, M; Finkler, N; Kindermann, M; Läer, S; Maack, C; Schäfers, HJ; Schaller, S; Schmidt, KI; Wuttke, H | 1 |
Abbott, JA; Broadstone, RV; Pyle, RL; Ward, DL | 1 |
Bøkenes, J; Osnes, JB; Qvigstad, E; Schiander, I; Sejersted, OM; Sjaastad, I; Skomedal, T; Solberg, L | 1 |
Magovern, M; Nikolaidis, LA; Parikh, P; Poornima, I; Shannon, RP; Shen, YT | 1 |
Boussemaere, M; Denef, C; Janssens, K; Kopka, K; Wagner, S | 1 |
Asari, K; Hanada, K; Kawana, J; Mita, M; Ogata, H; Saito, M | 1 |
Ahokas, RA; Bhattacharya, SK; Gerling, IC; Johnson, PL; Shahbaz, AU; Sun, Y; Weber, KT; Zhao, T; Zhao, W | 1 |
Horst, R; Katritch, V; Liu, JJ; Stevens, RC; Wüthrich, K | 1 |
Back, TG; Chen, PS; Chen, SR; Chua, SK; Lin, SF; Maruyama, M; Rubart-von der Lohe, M; Vembaiyan, K; Xiao, J; Zhou, Q | 1 |
Steinberg, SF; Zhang, F | 1 |
Andresen, BT; Chang, A; Huang, KM; Huang, Y; Jackson, EK; Kanassatega, RS; Liu, MM; Orlando, R; Parsa, C; Thakkar, A; Yeung, S | 1 |
Akhtar, M; Khanam, R; Najmi, AK; Yadav, CH | 1 |
Coelho, M; Correia, G; Medeiros, R; Moz, M; Ribeiro, L; Teixeira, A | 1 |
Deng, M; Guo, X; Jiang, Z; Liu, Y; Yu, J | 1 |
Abdel Baky, NA; Al-Mohanna, F; Bin-Dayel, AF; Fadda, LM; Mohammad, RA | 1 |
Fang, X; Li, N; Li, Z; Sun, Y; Wu, J; Yuan, J; Zhang, M; Zhang, Y; Zhao, R; Zhou, W | 1 |
Brill, A; Hale, GM; Jafferjee, M; Lymperopoulos, A; Marrero, C; McCrink, KA; Rodriguez, MM; Valero, TR | 1 |
Chen, H; Chen, X; Guo, H; Niu, X; Pan, C; Yi, T | 1 |
Hasan, W; Khan, F; Mudd, JO; Thornburg, KL; Toyooka, A; Tyrrell, C | 1 |
Du, XJ; Hu, HY; Kiriazis, H; Lu, Q; Nguyen, MN; Puthalakath, H; Sadoshima, J; Su, Y; Wang, LN; Zhao, WB; Ziemann, M | 1 |
Bouvier, M; Gmeiner, P; Hübner, H; Kaindl, JM; Picard, LP; Schmidt, MF; Stanek, M; Weikert, D | 1 |
Fukuda, K; Kai, S; Matsukawa, S; Seo, H; Suzuki, K | 1 |
Alamri, AS; Alhomrani, M; Almutiri, AH; Alsanie, WF; Alshammari, MS; Asdaq, SMB; Challa, O | 1 |
Awad, AS; Baraka, SA; El-Demerdash, E; El-Naga, RN; Elsherbini, DA; Tolba, MF | 1 |
Alamri, AS; Alhomrani, M; Alsanie, WF; Asdaq, SMB | 1 |
Cao, Y; Guo, J; Huang, B; Huo, S; Li, S; Lin, L; Lv, J; Men, L; Peng, D; Peng, L; Shi, W; Wang, M; Wang, Q | 1 |
2 review(s) available for isoproterenol and carvedilol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Nitric oxide and vascular reactivity in African American patients with hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Black or African American; Brachial Artery; Carbazoles; Carotid Arteries; Carvedilol; Coronary Vessels; Drug Resistance; Endothelium; Glucose-6-Phosphatase; Humans; Hypertension; Inflammation; Isoproterenol; Methacholine Chloride; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroglycerin; Nitroprusside; Propanolamines; Prosencephalon; Racial Groups; Regional Blood Flow; Risk Factors; Vascular Resistance; White People | 2003 |
7 trial(s) available for isoproterenol and carvedilol
Article | Year |
---|---|
Alpha 1-blocking properties of carvedilol during acute and chronic administration.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Carbazoles; Carvedilol; Double-Blind Method; Drug Interactions; Female; Heart Rate; Humans; Injections, Intravenous; Isoproterenol; Male; Middle Aged; Phenylephrine; Prazosin; Propanolamines; Random Allocation; Vasodilator Agents | 1992 |
Mechanism of the vasodilatory effect of carvedilol in normal volunteers: a comparison with labetalol.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Blood Pressure; Carbazoles; Carvedilol; Half-Life; Heart Rate; Humans; Isoproterenol; Labetalol; Phenylephrine; Propanolamines; Random Allocation; Vasodilation | 1987 |
Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Cold Temperature; Double-Blind Method; Exercise; Heart Rate; Hemodynamics; Humans; Hydralazine; Isoproterenol; Labetalol; Male; Middle Aged; Phenylephrine; Posture; Propanolamines; Propranolol; Vasodilator Agents | 1988 |
Clinical pharmacology of carvedilol in normal volunteers.
Topics: Adult; Angiotensin II; Blood Pressure; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Heart Rate; Humans; Isoproterenol; Kinetics; Labetalol; Male; Phenylephrine; Propanolamines; Random Allocation; Receptors, Adrenergic | 1987 |
The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Blood Pressure; Carbazoles; Carvedilol; Double-Blind Method; Exercise; Heart Rate; Humans; Isoproterenol; Labetalol; Male; Phenylephrine; Propanolamines; Vasodilator Agents | 1995 |
Using isoproterenol stress echocardiography to predict the response to carvedilol in patients with dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Contraindications; Echocardiography; Female; Follow-Up Studies; Heart Function Tests; Hemodynamics; Humans; Isoproterenol; Male; Middle Aged; Prognosis; Propanolamines; Treatment Outcome | 2001 |
Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Alleles; Allosteric Site; Binding Sites; Carbazoles; Cardiac Output; Carvedilol; Cross-Over Studies; Cytochrome P-450 CYP2D6; Dobutamine; Echocardiography, Stress; Genotype; Heart Atria; Heart Rate; Humans; Inactivation, Metabolic; Isoproterenol; Male; Metoprolol; Propanolamines; Protein Binding; Receptors, Adrenergic, beta; Up-Regulation | 2004 |
45 other study(ies) available for isoproterenol and carvedilol
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Single and repeated doses of the vasodilator/beta-adrenergic antagonist, carvedilol, block cirazoline- and isoproterenol-mediated hemodynamic responses in the conscious rat.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Carbazoles; Carvedilol; Hemodynamics; Imidazoles; Isoproterenol; Male; Prazosin; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Time Factors; Vasodilator Agents | 1992 |
Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Arteries; Azepines; Calcium Channel Blockers; Carbazoles; Carvedilol; Consciousness; Dose-Response Relationship, Drug; Hemodynamics; Isoproterenol; Male; Propanolamines; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Vasoconstrictor Agents; Vasodilation | 1991 |
Pharmacological characteristics of the stereoisomers of carvedilol.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Blood Pressure; Carbazoles; Carvedilol; Decerebrate State; Heart Rate; Hypertension; In Vitro Techniques; Isoproterenol; Methoxamine; Muscle Contraction; Muscle, Smooth, Vascular; Propanolamines; Rabbits; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Stereoisomerism | 1990 |
Pharmacological profile of carvedilol as a beta-blocking agent with vasodilating and hypotensive properties.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Dogs; Hemodynamics; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Propanolamines; Rabbits; Rats; Sympathomimetics; Vasodilator Agents | 1987 |
The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.
Topics: Adrenergic beta-Antagonists; Anesthesia; Animals; Carbazoles; Carvedilol; Decerebrate State; Guinea Pigs; Heart; Heart Rate; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Norepinephrine; Propanolamines; Rabbits; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Stereoisomerism | 1989 |
Alpha and beta adrenoceptor blocking action of carvedilol in the canine mesenteric artery and vein.
Topics: Action Potentials; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Dogs; Electrophysiology; Evoked Potentials; Female; Guinea Pigs; Isoproterenol; Male; Mesenteric Arteries; Mesenteric Veins; Norepinephrine; Propanolamines; Synaptic Transmission; Yohimbine | 1988 |
Acute effects of catecholamines on function of the rat right heart.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Carvedilol; Catecholamines; Female; Heart Rate; Isoproterenol; Metoprolol; Norepinephrine; Prazosin; Propanolamines; Rats; Rats, Sprague-Dawley; Ventricular Function, Right | 1993 |
Beta-adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy.
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Genetically Modified; Binding, Competitive; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Colforsin; Down-Regulation; GTP-Binding Protein alpha Subunits, Gi-Go; Guanylyl Imidodiphosphate; Heart Rate; Isoproterenol; Male; Neuropeptide Y; Pertussis Toxin; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Signal Transduction; Virulence Factors, Bordetella | 1998 |
Constitutively active mutants of the beta1-adrenergic receptor.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Amino Acid Substitution; Betaxolol; Carbazoles; Carvedilol; Cell Line; Cyclic AMP; Epinephrine; Humans; Imidazoles; Isoproterenol; Labetalol; Point Mutation; Practolol; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Recombinant Proteins; Timolol | 1999 |
Blockade of putative beta4- and beta1-adrenoceptors by carvedilol in ferret myocardium.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Ferrets; Heart Atria; Heart Ventricles; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardium; Propanolamines; Receptors, Adrenergic, beta; Sinoatrial Node | 1999 |
Carvedilol stimulates nitric oxide synthesis in rat cardiac myocytes.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Atenolol; Carbazoles; Carvedilol; Dactinomycin; Drug Synergism; Enzyme Induction; Enzyme Inhibitors; Guanidines; Heart; Interleukin-1; Isoproterenol; Muscle Proteins; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Nucleic Acid Synthesis Inhibitors; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Recombinant Proteins | 2000 |
Contribution of cardiovascular hypersensitivity to orthostatic hypertension and the extreme dipper phenomenon.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carbazoles; Cardiovascular System; Carvedilol; Female; Heart Rate; Humans; Hypertension; Isoproterenol; Norepinephrine; Phenylephrine; Posture; Propanolamines; Systole; Tilt-Table Test | 2000 |
Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Antioxidants; Bisoprolol; Carbazoles; Cardiovascular Agents; Carvedilol; Creatine Kinase; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Isoproterenol; Lipid Peroxidation; Male; Membrane Lipids; Myocardial Ischemia; Myocardium; Peroxidase; Propanolamines; Rabbits; Reperfusion Injury; Ventricular Pressure | 2000 |
Differential effects of carvedilol and metoprolol on isoprenaline-induced changes in beta-adrenoceptor density and systolic function in rat cardiac myocytes.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Carbazoles; Carvedilol; Cell Size; Cells, Cultured; Electric Stimulation; Guanylyl Imidodiphosphate; Isoproterenol; Male; Metoprolol; Microscopy, Phase-Contrast; Myocardium; Propanolamines; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Regression Analysis | 2001 |
Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium.
Topics: Adrenergic beta-Antagonists; Benzopyrans; Binding, Competitive; Bisoprolol; Carbazoles; Carvedilol; Ethanolamines; Female; Guanylyl Imidodiphosphate; Heart Ventricles; Humans; Imidazoles; In Vitro Techniques; Inhibitory Concentration 50; Isoproterenol; Male; Metoprolol; Middle Aged; Myocardial Contraction; Myocardium; Nebivolol; Propanolamines; Substrate Specificity; Sympathetic Nervous System; Sympathomimetics; Thermodynamics | 2001 |
Cardiovascular and renal effects of carvedilol in dogs with heart failure.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Carvedilol; Dog Diseases; Dogs; Echocardiography; Female; Glomerular Filtration Rate; Heart Rate; Isoproterenol; Kidney; Male; Mitral Valve Insufficiency; Phenylephrine; Propanolamines; Ventricular Remodeling | 2002 |
Hemodynamic effects of orally administered carvedilol in healthy conscious dogs.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Carvedilol; Dogs; Heart Failure; Heart Rate; Hemodynamics; Isoproterenol; Phenylephrine; Propanolamines; Pulmonary Wedge Pressure; Random Allocation | 2005 |
Carvedilol blockade of alpha1- and beta-adrenoceptor induced inotropic responses in rats with congestive heart failure.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Heart Failure; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardial Infarction; Norepinephrine; Papillary Muscles; Phenylephrine; Propanolamines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Vasoconstrictor Agents; Vasodilator Agents | 2005 |
The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy.
Topics: Adrenergic Antagonists; Adrenergic beta-Agonists; Animals; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Dogs; Heart Rate; Hemodynamics; Isoproterenol; Metoprolol; Myocardium; Propanolamines; Regional Blood Flow; Ventricular Function, Left | 2006 |
Beta1-adrenoceptors in rat anterior pituitary may be constitutively active. Inverse agonism of CGP 20712A on basal 3',5'-cyclic adenosine 5'-monophosphate levels.
Topics: Adenylyl Cyclases; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Animals; Carbazoles; Carvedilol; Cell Aggregation; Cells, Cultured; Cyclic AMP; Drug Inverse Agonism; Enzyme Activation; Imidazoles; Isoproterenol; Male; Pertussis Toxin; Pituitary Gland, Anterior; Propanolamines; Rats; Rats, Wistar; Receptors, Adrenergic, beta-1; Substrate Specificity | 2008 |
Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
Topics: Adenylyl Cyclases; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Cardiomegaly; Carvedilol; Cyclic AMP; Disease Models, Animal; Heart Failure; Heart Rate; Isoproterenol; Male; Metoprolol; Myocardium; Propanolamines; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Time Factors; Ventricular Function, Left | 2008 |
Calcium and zinc dyshomeostasis during isoproterenol-induced acute stressor state.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Antioxidants; Calcium; Capillary Permeability; Carbazoles; Carvedilol; Endothelium; Homeostasis; In Vitro Techniques; Isoproterenol; Male; Metallothionein; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Necrosis; Oxidative Stress; Propanolamines; Quercetin; Rats; Rats, Sprague-Dawley; Sarcolemma; Stress, Physiological; Superoxide Dismutase; Zinc | 2011 |
Biased signaling pathways in β2-adrenergic receptor characterized by 19F-NMR.
Topics: Adrenergic beta-2 Receptor Agonists; Arrestins; beta-Arrestins; Binding Sites; Carbazoles; Carvedilol; Cytoplasm; Drug Partial Agonism; Fluorine; Isoetharine; Isoproterenol; Ligands; Models, Molecular; Nuclear Magnetic Resonance, Biomolecular; Propanolamines; Protein Conformation; Protein Structure, Secondary; Receptors, Adrenergic, beta-2; Signal Transduction; Structure-Activity Relationship | 2012 |
Carvedilol analogue inhibits triggered activities evoked by both early and delayed afterdepolarizations.
Topics: Action Potentials; Analysis of Variance; Animals; Calcium; Carbazoles; Carvedilol; Heart Ventricles; Isoproterenol; Long QT Syndrome; Membrane Potentials; Mice; Morpholines; Propanolamines; Rabbits | 2013 |
S49G and R389G polymorphisms of the β₁-adrenergic receptor influence signaling via the cAMP-PKA and ERK pathways.
Topics: Blotting, Western; Carbazoles; Carvedilol; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; HEK293 Cells; Humans; Isoproterenol; MAP Kinase Signaling System; Membrane Microdomains; Mutation, Missense; Plasmids; Propanolamines; Receptors, Adrenergic, beta-1 | 2013 |
Prevention of skin carcinogenesis by the β-blocker carvedilol.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adrenergic beta-Antagonists; Animals; Anticarcinogenic Agents; Atenolol; Carbazoles; Carvedilol; Cell Adhesion; Cell Line; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Isoproterenol; Mice; Mutation; Neoplasm Transplantation; Propanolamines; Skin Neoplasms; Transcription Factor AP-1 | 2015 |
Cardioprotective role of H₃R agonist imetit on isoproterenol-induced hemodynamic changes and oxidative stress in rats.
Topics: Adrenergic beta-Agonists; Animals; Antioxidants; Biomarkers; Blood Pressure; Body Height; Body Weight; Carbazoles; Cardiotonic Agents; Carvedilol; Heart Diseases; Heart Rate; Hemodynamics; Histamine Agonists; Humans; Imidazoles; Isoproterenol; Male; Myocardium; Oxidative Stress; Propanolamines; Rats; Rats, Wistar; Thiourea | 2015 |
Antiproliferative effects of β-blockers on human colorectal cancer cells.
Topics: Adenocarcinoma; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Atenolol; Carbazoles; Carvedilol; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Epinephrine; HT29 Cells; Humans; Isoproterenol; Norepinephrine; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Signal Transduction | 2015 |
Capillary electrophoretic enantioseparation of basic drugs using a new single-isomer cyclodextrin derivative and theoretical study of the chiral recognition mechanism.
Topics: Brompheniramine; Carbazoles; Carvedilol; Chlorpheniramine; Clenbuterol; Cyclodextrins; Econazole; Electrophoresis, Capillary; Isoproterenol; Miconazole; Molecular Structure; Pheniramine; Procaterol; Propanolamines; Stereoisomerism; Terbutaline; Tropanes | 2016 |
Effect of aliskiren and carvedilol on expression of Ca(2+)/calmodulin-dependent protein kinase II δ-subunit isoforms in cardiac hypertrophy rat model.
Topics: Amides; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Carbazoles; Cardiomegaly; Carvedilol; Creatine Kinase, MB Form; Disease Models, Animal; Drug Therapy, Combination; Fumarates; Heart; Isoproterenol; Male; Myocardium; Organ Size; Propanolamines; Protein Isoforms; Rats, Wistar; Real-Time Polymerase Chain Reaction; Renin; Renin-Angiotensin System; Troponin T | 2016 |
Single-molecule imaging reveals the stoichiometry change of β2-adrenergic receptors by a pharmacological biased ligand.
Topics: Carbazoles; Carvedilol; Green Fluorescent Proteins; HEK293 Cells; Humans; Isoproterenol; Ligands; Microscopy, Fluorescence; Optical Imaging; Propanolamines; Propranolol; Receptors, Adrenergic, beta-2; Stereoisomerism | 2016 |
β
Topics: Animals; beta-Arrestins; Carbazoles; Carvedilol; Cells, Cultured; Isoproterenol; Myocytes, Cardiac; Polymorphism, Genetic; Propanolamines; Protein Binding; Rats; Rats, Wistar; Receptors, Adrenergic, beta-1; Tropism | 2016 |
A novel in situ strategy for the preparation of a β-cyclodextrin/polydopamine-coated capillary column for capillary electrochromatography enantioseparations.
Topics: beta-Cyclodextrins; Capillary Electrochromatography; Carbazoles; Carvedilol; Epinephrine; Indoles; Isoproterenol; Norepinephrine; Polymers; Propanolamines; Stereoisomerism; Terbutaline; Tryptophan; Verapamil | 2017 |
The neuropeptide galanin promotes an anti-thrombotic phenotype on endocardial endothelial cells from heart failure patients.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Antithrombins; Carbazoles; Carvedilol; Cells, Cultured; Endothelial Cells; Galanin; Heart Failure; Heart Ventricles; Humans; Isoproterenol; Male; Middle Aged; Neuropeptide Y; Phenotype; Propanolamines; Propranolol; Protein Multimerization; Thrombin | 2017 |
Stimulation of β-adrenoceptors up-regulates cardiac expression of galectin-3 and BIM through the Hippo signalling pathway.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bcl-2-Like Protein 11; Cardiovascular Diseases; Carvedilol; Cell Line; Dose-Response Relationship, Drug; Galectin 3; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Propanolamines; Propranolol; Rats; Receptors, Adrenergic, beta-3; Signal Transduction; Up-Regulation | 2019 |
Hybridization of β-Adrenergic Agonists and Antagonists Confers G Protein Bias.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; beta-Arrestins; Carvedilol; Catechols; Drug Design; GTP-Binding Proteins; Humans; Hydrogen Bonding; Indicators and Reagents; Isoproterenol; Ligands; Mice; Models, Molecular; Molecular Dynamics Simulation; Salmeterol Xinafoate | 2019 |
Activation of the β-adrenergic receptor exacerbates lipopolysaccharide-induced wasting of skeletal muscle cells by increasing interleukin-6 production.
Topics: Animals; Carvedilol; CCAAT-Enhancer-Binding Protein-delta; Epinephrine; Gene Expression Regulation; Humans; Interleukin-6; Isoproterenol; Lipopolysaccharides; Mice; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Myoblasts; NF-kappa B; Nitriles; Norepinephrine; Oxazolidinones; Receptors, Adrenergic, beta; SKP Cullin F-Box Protein Ligases; STAT3 Transcription Factor; Sulfones | 2021 |
Cytoprotective Potential of Aged Garlic Extract (AGE) and Its Active Constituent, S-allyl-l-cysteine, in Presence of Carvedilol during Isoproterenol-Induced Myocardial Disturbance and Metabolic Derangements in Rats.
Topics: Animals; Antioxidants; Carvedilol; Catalase; Creatine Kinase, MB Form; Cysteine; Female; Garlic; Heart; Hemodynamics; Isoproterenol; L-Lactate Dehydrogenase; Myocardium; Necrosis; Plant Extracts; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2021 |
Rosuvastatin and low-dose carvedilol combination protects against isoprenaline-induced myocardial infarction in rats: Role of PI3K/Akt/Nrf2/HO-1 signalling.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Anticholesteremic Agents; Apoptosis; Carvedilol; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Heme Oxygenase (Decyclizing); Isoproterenol; Male; Myocardial Infarction; NF-E2-Related Factor 2; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rosuvastatin Calcium; Signal Transduction | 2021 |
Cardioprotective Potential of Garlic Oil and Its Active Constituent, Diallyl Disulphide, in Presence of Carvedilol during Chronic Isoprenaline Injection-Mediated Myocardial Necrosis in Rats.
Topics: Allyl Compounds; Animals; Antioxidants; Cardiotonic Agents; Carvedilol; Catalase; Disease Models, Animal; Disulfides; Garlic; Heart; Isoproterenol; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 2021 |
IL-6/gp130/STAT3 signaling contributed to the activation of the PERK arm of the unfolded protein response in response to chronic β-adrenergic stimulation.
Topics: Adrenergic Agents; Animals; Carvedilol; Cytokine Receptor gp130; Endoribonucleases; Interleukin-6; Isoproterenol; Mice; Mice, Inbred C57BL; Protein Serine-Threonine Kinases; Receptors, Adrenergic; Unfolded Protein Response | 2023 |